Magenta Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Magenta Therapeutics Inc
TickerDNTH
CIK #0001690585
CUSIP252828108
SectorLife Sciences - Pharmaceutical Preparations
Address50 Hampshire Street, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001690585] 10-K
[0001690585] 10-Q
[0001690585] 3
[0001690585] 4
[0001690585] 5
[0001690585] 8-K
[0001690585] D
[0001690585] SC 13D
[0001690585] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
RA Capital Management LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 9.99
BCLS Fund III Investments LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 81949.99
Avidity Partners Management LP Dianthus Therapeutics Inc /DE/ [2024-01-31] 0.9
FMR LLC Dianthus Therapeutics Inc /DE/ [2023-11-13] 0.0
5AM Partners VII LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 7.1
Venrock Healthcare Capital Partners III LP Dianthus Therapeutics Inc /DE/ [2023-09-21] 6.3
Viridian LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 8194.0
Fairmount Funds Management LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 819412.7
Citadel Advisors LLC Magenta Therapeutics Inc [2023-05-15] 6.5
Tang Capital Partners LP Magenta Therapeutics Inc [2023-02-13] 9.7
RA Capital Management LP Magenta Therapeutics Inc [2022-09-26] 6.09
Aquilo Capital Management LLC Magenta Therapeutics Inc [2022-02-14] 5.4
Deep Track Capital LP Magenta Therapeutics Inc [2021-05-14] 7.14
Atlas Venture Fund X LP Magenta Therapeutics Inc [2020-07-14] 8.7
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2020-02-14] 10.52
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2019-06-10] 10.6
Eventide Asset Management LLC Magenta Therapeutics Inc [2019-02-13] 8.0
Third Rock Ventures GP IV LP Magenta Therapeutics Inc [2019-02-13] 24.2
Atlas Venture Fund X LP Magenta Therapeutics Inc [2019-02-13] 14.6
GV 2016 LP Magenta Therapeutics Inc [2019-02-12] 10.07
Casdin Capital LLC Magenta Therapeutics Inc [2018-07-02] 5.9
Form 3/4/5 Filer 2011 - 2024
Dianthus Therapeutics, Inc. /DE/
Fairmount Funds Management LLC
Kiselak Tomas
Romano Steven J.
Moulder Leon O Jr
Carr Edward
Veness Adam M
Randhawa Simrat
Savitz Ryan
Garcia Marino
Violin Jonathan
Soteropoulos Paula
McGeorge Anne
Lawton Alison Frances
Harwin Peter Evan
Avidity Partners Management LP
Witzke David Roy
Meng Lei
Avidity Partners Management (GP) LLC
Gregory Michael David
TRV GP IV LLC
Third Rock Ventures IV, L.P.
Third Rock Ventures GP IV, L.P.
Stants Kristen
Beetham Thomas W.
Mahoney Stephen F.
Deardorf Caren
Gardner Jason
Vasconcelles Michael
Olson Lisa
Humphrey Jeffrey
Nichols David Wayne
Albers Jeffrey W.
Booth Bruce
Daniel Thomas O
Ronneberg Amy L
Scadden David
Borisy Alexis
Bonney Michael W
Davis John C Jr
Zdraveski Zoran
Atlas Venture Fund X, L.P.
Driscoll Cindy
Atlas Venture Opportunity Fund I, L.P.
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Associates Opportunity I, L.P.
Byers Blake
Ryan Jason
Isacson Christina K
Cooke Michael P
Atlas Venture Associates X LP
Atlas Venture Associates X, LLC
GV 2016 LP
Alphabet Inc.
GV 2016 GP LP
GV 2016 GP LLC
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2024-06-30] DFND 4,402,420.0 4,402,420.0
Bain Capital Life Sciences Investors, LLC [2024-06-30] SOLE 3,013,423.0 3,013,423.0
Avidity Partners Management LP [2024-06-30] SOLE 2,917,231.0 2,917,231.0
Fairmount Funds Management LLC [2024-06-30] SOLE 2,762,837.0 2,762,837.0
RA Capital Management LP [2024-06-30] SOLE 2,333,000.0 2,333,000.0
VR Adviser LLC [2024-06-30] SOLE 2,094,373.0 2,094,373.0
Octagon Capital Advisors LP [2024-06-30] SOLE 1,746,667.0 1,746,667.0
BlackRock Finance, Inc. [2024-06-30] SOLE 1,575,616.0 1,603,547.0
5AM Venture Management LLC [2024-06-30] SOLE 1,232,965.0 1,232,965.0
Vanguard Group Inc [2024-06-30] SOLE 0.0 1,216,738.0
Great Point Partners LLC [2024-06-30] DFND 0.0 757,929.0
Janus Henderson Group PLC [2024-06-30] DFND 0.0 675,664.0
RTW Investments LP [2024-06-30] SOLE 666,667.0 666,667.0
Vestal Point Capital LP [2024-06-30] SOLE 600,000.0 600,000.0
Geode Capital Management LLC [2024-06-30] DFND 498,920.0 498,920.0
State Street Corp [2024-06-30] DFND 384,490.0 407,706.0
Braidwell LP [2024-06-30] SOLE 366,851.0 366,851.0
Tang Capital Management LLC [2024-06-30] OTR 0.0 264,692.0
Woodline Partners LP [2024-06-30] SOLE 250,333.0 250,333.0
Adage Capital Partners GP LLC [2024-06-30] SOLE 250,000.0 250,000.0
Alphabet Inc. [2024-06-30] DFND 0.0 208,697.0
Point72 Asset Management LP [2024-06-30] DFND 0.0 174,200.0
Atlas Venture Life Science Advisors LLC [2024-06-30] SOLE 136,979.0 136,979.0
Marshall Wace LLP [2024-06-30] OTR 0.0 108,199.0
Renaissance Technologies LLC [2024-06-30] SOLE 88,604.0 88,604.0
Nuveen Asset Management LLC [2024-06-30] DFND 86,771.0 86,771.0
Bank of New York Mellon Corp [2024-06-30] DFND 66,433.0 80,935.0
Charles Schwab Investment Management Inc [2024-06-30] SOLE 68,567.0 68,567.0
Northern Trust Corp [2024-06-30] DFND 12.0 54,689.0
Goldman Sachs Group Inc [2024-06-30] DFND 41,869.0 41,869.0
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com